Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Health Technology Co., Ltd. (WHTC) is a high-tech biotechnology company specializing in the research, development, and manufacturing of in vitro diagnostic (IVD) reagents and instruments. Based in Wuhan, China, the company focuses on point-of-care testing (POCT) solutions, providing rapid diagnostic kits for infectious diseases, cardiovascular markers, and inflammatory conditions. WHTC gained significant international recognition during the COVID-19 pandemic for its rapid antigen and antibody test kits, which received various global certifications. Utilizing advanced platforms such as colloidal gold and fluorescence immunochromatography, the company delivers efficient and reliable diagnostic tools to hospitals, clinics, and laboratories worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on WHTC.